entity

CMA

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CMA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4Connections
1Hypotheses
0Analyses
1Outgoing
3Incoming
1Experiments
0Debates

No AI portrait yet

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

CMA Activation Therapy Evidence Synthesis

evidence · 1130 words

Outgoing (1)

TargetRelationTypeStr
ROSregulatesphenotype0.64

Incoming (3)

SourceRelationTypeStr
35000546is upregulated to removepaper0.90
HSP70associated_withprotein0.80
LAMP2Abiomarker_forgene0.80

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
LAMP2A Liquid-Liquid Phase Separation Defects in Dopaminergi 0.783 neurodegeneration -

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (1)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Chaperone-Mediated Autophagy Dysfunction in PD - Experiment Design clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning CMA in their description or question text

No additional research found